Medical device manufacturer Owen Mumford is introducing Unifine Ultra, a one-of-a-kind home use pen needle designed to offer the ultimate solution to help improve patient compliance and enhance the injection experience for diabetics.
Unifine Ultra is ergonomically constructed for ease of use. The unique design includes a flat base to help improve skin contact and enhance comfort in addition to the large hub design, which aides with grip and handling. The Unifine Ultra pen needle incorporates Owen Mumford’s patented SafeControl Technology, a needle lock-out feature that secures both ends of the needle. This patented lock-out feature assists in encouraging patient compliance and makes Unifine Ultra the optimal choice for convenience at home or on-the-go.
“I am incredibly proud of the work completed by our product management, marketing, and research and development teams,” said Travis Shaw, executive vice president at Owen Mumford. “Their dedication and tireless efforts in assisting to bring Unifine Ultra to market is a testament to Owen Mumford’s mission, "Making a World of Difference to a World of People." The Unifine Ultra introduction compliments Owen Mumford’s already expansive pen needle portfolio by adding unique features and innovative technologies, with the consumer in mind.”
Unifine Ultra is available in sizes 4mmx32G, 5mmx31G, 6mmx31G and 8mmx31G.